• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测乳腺癌异种移植瘤对PI3K/mTOR抑制反应的定量(31)P高分辨魔角旋转磁共振波谱分析

Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.

作者信息

Esmaeili Morteza, Bathen Tone F, Engebråten Olav, Mælandsmo Gunhild M, Gribbestad Ingrid S, Moestue Siver A

机构信息

Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

出版信息

Magn Reson Med. 2014 Jun;71(6):1973-81. doi: 10.1002/mrm.24869. Epub 2013 Jul 22.

DOI:10.1002/mrm.24869
PMID:23878023
Abstract

PURPOSE

Phospholipid metabolites are of importance in cancer studies, and have been suggested as candidate metabolic biomarkers for response to targeted anticancer drugs. The purpose of this study was to develop a phosphorus ((31) P) high resolution magic angle spinning magnetic resonance spectroscopy protocol for quantification of phosphorylated metabolites in intact cancer tissue.

METHODS

(31) P spectra were acquired on a 14.1 T spectrometer with a triplet (1) H/(13) C/(31) P MAS probe. Quantification of metabolites was performed using the PULCON principle. Basal-like and luminal-like breast cancer xenografts were treated with the dual PI3K/mTOR inhibitor BEZ235, and the impact of treatment on the concentration of phosphocholine, glycerophosphocholine, phosphoethanolamine and glycerophosphoethanolamine was evaluated.

RESULTS

In basal-like xenografts, BEZ235 treatment induced a significant decrease in phosphoethanolamine (-25.6%, P = 0.01) whilst phosphocholine (16.5%, P = 0.02) and glycerophosphocholine (37.3%, P < 0.001) were significantly increased. The metabolic changes could partially be explained by increased levels of phospholipase A2 group 4A (PLA2G4A).

CONCLUSION

(31) P high resolution magic angle spinning magnetic resonance spectroscopy is a useful method for quantitative assessment of metabolic responses to PI3K inhibition. Using the PULCON principle for quantification, the levels of phosphocholine, glycerophosphocholine, phosphoethanolamine, and glycerophosphoethanolamine could be evaluated with high precision and accuracy.

摘要

目的

磷脂代谢产物在癌症研究中具有重要意义,并且已被认为是针对靶向抗癌药物反应的候选代谢生物标志物。本研究的目的是开发一种用于完整癌症组织中磷酸化代谢产物定量的磷(³¹P)高分辨率魔角旋转磁共振波谱方案。

方法

在配备三重共振(¹H/¹³C/³¹P)魔角旋转探头的14.1 T光谱仪上采集³¹P谱。使用PULCON原理进行代谢产物的定量。用双重PI3K/mTOR抑制剂BEZ235处理基底样和腔面样乳腺癌异种移植瘤,并评估治疗对磷酸胆碱、甘油磷酸胆碱、磷酸乙醇胺和甘油磷酸乙醇胺浓度的影响。

结果

在基底样异种移植瘤中,BEZ235治疗导致磷酸乙醇胺显著降低(-25.6%,P = 0.01),而磷酸胆碱(16.5%,P = 0.02)和甘油磷酸胆碱(37.3%,P < 0.001)显著增加。代谢变化部分可由磷脂酶A2第4A组(PLA2G4A)水平升高来解释。

结论

³¹P高分辨率魔角旋转磁共振波谱是定量评估对PI3K抑制的代谢反应的有用方法。使用PULCON原理进行定量,可以高精度和准确性评估磷酸胆碱、甘油磷酸胆碱、磷酸乙醇胺和甘油磷酸乙醇胺的水平。

相似文献

1
Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.用于检测乳腺癌异种移植瘤对PI3K/mTOR抑制反应的定量(31)P高分辨魔角旋转磁共振波谱分析
Magn Reson Med. 2014 Jun;71(6):1973-81. doi: 10.1002/mrm.24869. Epub 2013 Jul 22.
2
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer.基底样乳腺癌中对PI3K抑制反应的代谢生物标志物。
Breast Cancer Res. 2013 Feb 28;15(1):R16. doi: 10.1186/bcr3391.
3
In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts.用于人乳腺癌异种移植瘤代谢谱分析的体内³¹P磁共振波谱成像(MRSI)
J Magn Reson Imaging. 2015 Mar;41(3):601-9. doi: 10.1002/jmri.24588. Epub 2014 Feb 14.
4
Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.通过对完整肿瘤样本进行高分辨率魔角旋转质子核磁共振光谱分析发现,黑色素瘤肿瘤在西司他丁作用下获得了一种新的磷脂代谢表型。
Cancer Res. 2002 Mar 15;62(6):1890-7.
5
Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.体内 BEZ235 对胃癌生长的控制与 PI3K/mTOR 靶标抑制无关,而与 [18F]FLT 摄取有关。
Clin Cancer Res. 2011 Aug 15;17(16):5322-32. doi: 10.1158/1078-0432.CCR-10-1659. Epub 2011 Jun 28.
6
Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts.通过人乳腺癌异种移植瘤的局部(31)P磁共振波谱在体内定量胆碱代谢物对多西他赛治疗的反应,并通过细胞提取物的高分辨率(31)P核磁共振波谱在体外进行定量。
Magn Reson Med. 2007 Aug;58(2):270-80. doi: 10.1002/mrm.21333.
7
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.不同的胆碱代谢特征与基底样和腔面样乳腺癌异种移植模型基因表达的差异有关。
BMC Cancer. 2010 Aug 17;10:433. doi: 10.1186/1471-2407-10-433.
8
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.胆碱激酶抑制剂MN58b在人类癌症模型中的无创磁共振波谱药效学标志物
Cancer Res. 2006 Jan 1;66(1):427-34. doi: 10.1158/0008-5472.CAN-05-1338.
9
Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.应用 HRMAS-MR 波谱技术对不同临床预后的乳腺癌患者进行代谢产物定量分析。
NMR Biomed. 2010 May;23(4):424-31. doi: 10.1002/nbm.1478. Epub 2010 Jan 25.
10
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.NVP-BEZ235,一种双PI3K/mTOR抑制剂,可阻止PI3K信号传导并抑制具有激活PI3K突变的癌细胞的生长。
Cancer Res. 2008 Oct 1;68(19):8022-30. doi: 10.1158/0008-5472.CAN-08-1385.

引用本文的文献

1
Magnetic Resonance Imaging for Translational Research in Oncology.用于肿瘤学转化研究的磁共振成像
J Clin Med. 2019 Nov 6;8(11):1883. doi: 10.3390/jcm8111883.
2
Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.关注癌症胆碱磷脂代谢中的甘油磷酸胆碱途径。
NMR Biomed. 2019 Oct;32(10):e4112. doi: 10.1002/nbm.4112. Epub 2019 Jun 11.
3
HR-MAS NMR Based Quantitative Metabolomics in Breast Cancer.基于高分辨魔角旋转核磁共振的乳腺癌定量代谢组学
Metabolites. 2019 Jan 22;9(2):19. doi: 10.3390/metabo9020019.
4
Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma.人类结直肠癌和前列腺癌临床前模型中对 AKT 抑制剂 MK-2206 反应的代谢生物标志物。
Br J Cancer. 2018 Oct;119(9):1118-1128. doi: 10.1038/s41416-018-0242-3. Epub 2018 Oct 31.
5
Probing the PI3K/Akt/mTor pathway using P-NMR spectroscopy: routes to glycogen synthase kinase 3.用 P-NMR 光谱探测 PI3K/Akt/mTOR 通路:通往糖原合成酶激酶 3 的途径。
Sci Rep. 2016 Nov 4;6:36544. doi: 10.1038/srep36544.
6
Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer.高分辨率魔角旋转磁共振波谱特征在乳腺癌代谢特征分析中的瘤内一致性
Medicine (Baltimore). 2016 Apr;95(15):e3398. doi: 10.1097/MD.0000000000003398.
7
Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation.PI3K抑制后血浆代谢组学变化作为药效学生物标志物:从临床前发现到I期试验评估
Mol Cancer Ther. 2016 Jun;15(6):1412-24. doi: 10.1158/1535-7163.MCT-15-0815. Epub 2016 Apr 5.
8
Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS).使用离体高分辨魔角旋转(HRMAS)磁共振波谱(MRS)评估癌症代谢组学。
Metabolites. 2016 Mar 22;6(1):11. doi: 10.3390/metabo6010011.
9
MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival.用双重PI3K/mTOR抑制剂和替莫唑胺治疗的胶质母细胞瘤模型的磁共振成像研究:代谢变化与生存期延长相关
Mol Cancer Ther. 2016 May;15(5):1113-22. doi: 10.1158/1535-7163.MCT-15-0769. Epub 2016 Feb 16.
10
Metabolomic changes during cellular transformation monitored by metabolite-metabolite correlation analysis and correlated with gene expression.通过代谢物-代谢物相关性分析监测细胞转化过程中的代谢组学变化,并与基因表达相关联。
Metabolomics. 2015;11(6):1848-1863. doi: 10.1007/s11306-015-0838-z. Epub 2015 Aug 11.